AMI Pharm Co., Ltd.
PrivateLast Round
Private Equity
Sep 9, 2026
Total Funding Raised
$38M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AMI Pharm Co., Ltd. operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Private Equity round in September 2026.
AMI Pharm Co., Ltd. is a pharmaceutical company that develops injectable treatments for localized fat reduction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMI Pharm Co., Ltd. Comparables
Compare AMI Pharm Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Raziel Therapeutics | 84% | |
| Caliway Biopharmaceuticals | 84% | |
| Leios Therapeutics | 83% |
For institutional investors. Book with your work email.
AMI Pharm Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Sep 9, 2026 | ||||
| Series C | Feb 25, 2026 |
For institutional investors. Book with your work email.
AMI Pharm Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hyundai Investment Partners | Private Equity |
| Dongwon Technology Investment | Private Equity |
| Korea Investment Partners | Series C |
| Hyundai Technology Investment | Private Equity |
| Daishin Securities | Private Equity |
| NH Nonghyup Bank | Private Equity |
| Samho Green Investment | Private Equity |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2026
$15.3M round from Hyundai Investment Partners and others.
- Feb 25, 2026
$5M round led by Industrial Bank of Korea and Korea Investment Partners.
For institutional investors. Book with your work email.
AMI Pharm Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AMI Pharm Co., Ltd.'s valuation, stock price, and market status.
Is AMI Pharm Co., Ltd. a public or private company?
AMI Pharm Co., Ltd. is a private company.
What is the current stock price of AMI Pharm Co., Ltd.?
AMI Pharm Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks AMI Pharm Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AMI Pharm Co., Ltd. worth (valuation)?
Valuation information for AMI Pharm Co., Ltd. is not publicly available.
Can I buy AMI Pharm Co., Ltd. stock?
AMI Pharm Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AMI Pharm Co., Ltd.'s last funding round?
AMI Pharm Co., Ltd.'s most recent funding round was Private Equity on September 9, 2026.
Who are the main investors in AMI Pharm Co., Ltd.?
Key investors in AMI Pharm Co., Ltd. include Hyundai Investment Partners, Dongwon Technology Investment, Korea Investment Partners, Hyundai Technology Investment, Daishin Securities.
Will AMI Pharm Co., Ltd. IPO soon?
No public IPO plans have been announced for AMI Pharm Co., Ltd..
How can I track AMI Pharm Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in AMI Pharm Co., Ltd.'s shares on secondary markets.